NCPA Endorses Rep. Marino Bill to Reduce Prescription Drug Abuse

Published Online: Wednesday, February 19, 2014
Follow Pharmacy_Times:

Alexandria, Va. Feb. 19, 2014 - The National Community Pharmacists Association (NCPA) today endorsed legislation recently introduced by U.S. Rep. Tom Marino (R-Pa.) that is intended to reduce the abuse of prescription drugs by fostering greater collaboration among stakeholders and implementing new safeguards.

"America is in the throes of a prescription drug abuse crisis," said NCPA CEO B. Douglas Hoey, RPh, MBA. "No one wants to address it more than community pharmacists, who are the experts in the proper use of prescription medication and who understand the consequences of drug diversion and abuse. We commend Representative Marino for his leadership in this area. Our support for this legislation reflects the constructive approach that NCPA has taken to working with federal and state policymakers, law enforcement and all stakeholders in support of effective, practical solutions to the prescription drug abuse epidemic, while preserving access to medication for those with legitimate health needs."

The Ensuring Patient Access and Effective Drug Enforcement Act (H.R. 4069) would amend the Controlled Substances Act and implement the following reforms:
  • Require manufacturers and distributors registered with the Drug Enforcement Administration (DEA) to ensure that their employees with access to controlled substances satisfy criminal background checks and drug tests.
  • Establish a Combating Prescription Drug Abuse Working Group of federal and state officials as well as private sector stakeholders dedicated to examining ways to reduce abuse and diversion. Members of the panel would include a representative of community pharmacy. It would also be a forum by which concerns of independent community pharmacies may be addressed.

In presentations to Congress and to the Food and Drug Administration and DEA, NCPA has recommended steps to combat prescription drug abuse, while protecting patients. They include utilization of electronic prescription drug monitoring programs and tracking systems, more effective education of prescribers, shutting down rogue pain clinics, offering more disposal options for excess medications and more scrutiny of controlled substances delivered by mail order pharmacies.
Related Articles
The National Association of Boards of Pharmacy in conjunction with various other stakeholder organizations has recently released a consensus document titled “Stakeholders’ Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances.”
The National Community Pharmacists Association today praised a Medicare final regulation to discourage Medicare Part D prescription drug plans from paying long-term care pharmacies lower, prorated dispensing fees for "short-cycle" prescriptions.
Seniors would have more convenient access to discounted or "preferred" copays for prescription drugs at their pharmacy of choice under new bipartisan legislation introduced recently and endorsed today by the National Community Pharmacists Association.
The Corrective Action Plan that federal Medicare officials have requested of Aetna is an important first step and the Centers for Medicare & Medicaid Services should go one further by issuing new guidance to all Medicare Part D prescription drug plan sponsors to prevent a 2016 repeat of the Aetna problems experienced in early 2015.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times